Cargando…
Field safety study of VANGUARD®crLyme: A vaccine for the prevention of Lyme disease in dogs
Here we report the results of a large-scale pre-license safety study in which two serials of VANGUARD®crLyme, a vaccine for canine Lyme disease, were tested in its target population (dogs) under the conditions of its intended use. Six-hundred and twenty dogs, from three distinct geographic regions o...
Autores principales: | Marconi, Richard T., Honsberger, Nicole, Teresa Winkler, M., Sobell, Nikki, King, Vickie L., Wappel, Sharon, Hoevers, Jacquelien, Xu, Zach, Millership, Jason |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733143/ https://www.ncbi.nlm.nih.gov/pubmed/33336186 http://dx.doi.org/10.1016/j.jvacx.2020.100080 |
Ejemplares similares
-
VANGUARD®crLyme: A next generation Lyme disease vaccine that prevents B. burgdorferi infection in dogs
por: Marconi, Richard T., et al.
Publicado: (2020) -
Comparative analysis of antibody responses to outer surface protein (Osp)A and OspC in dogs vaccinated with Lyme disease vaccines
por: Camire, A.C., et al.
Publicado: (2021) -
Comparison of effectiveness of cefovecin, doxycycline, and amoxicillin for the treatment of experimentally induced early Lyme borreliosis in dogs
por: Wagner, Bettina, et al.
Publicado: (2015) -
The Vanguard
Publicado: (1888) -
An Atypical Case of Lyme Disease Presenting With Lyme Carditis
por: Najam, Usman S, et al.
Publicado: (2023)